1. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. Tumours of the testis and paratesticular tissue. Tumours of the urinary system and male genital organs. 2004. Lyon: IARC Press;240–242.
2. Parker C, Milosevic M, Panzarella T, Banerjee D, Jewett M, Catton C, et al. The prognostic significance of the tumour infiltrating lymphocyte count in stage I testicular seminoma managed by surveillance. Eur J Cancer. 2002. 38:2014–2019.
3. Yakirevich E, Lefel O, Sova Y, Stein A, Cohen O, Izhak OB, et al. Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma. J Pathol. 2002. 196:67–75.
4. Torres A, Casanova JF, Nistal M, Regadera J. Quantification of immunocompetent cells in testicular germ cell tumours. Histopathology. 1997. 30:23–30.
5. Nakanoma T, Nakamura K, Deguchi N, Fujimoto J, Tazaki H, Hata J. Immunohistological analysis of tumour infiltrating lymphocytes in seminoma using monoclonal antibodies. Virchows Arch A Pathol Anat Histopathol. 1992. 421:409–413.
6. Rajashekhar G, Loganath A, Roy AC, Mongelli JM. Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines. Gynecol Oncol. 2003. 91:101–111.
7. Knoeller S, Lim E, Aleta L, Hertwig K, Dudenhausen JW, Arck PC. Distribution of immunocompetent cells in decidua of controlled and uncontrolled (choriocarcinoma/hydatidiform mole) trophoblast invasion. Am J Reprod Immunol. 2003. 50:41–47.
8. Ellis SA, Palmer MS, McMichael AJ. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. J Immunol. 1990. 144:731–735.
9. Yamada H, Polgar K, Hill JA. Cell-mediated immunity to trophoblast antigens in women with recurrent spontaneous abortion. Am J Obstet Gynecol. 1994. 170:1339–1344.
10. Kilic M, Flossmann E, Flossmann O, Vogelsang H, Junker U, Chaouat G, et al. Jeg-3 human choriocarcinoma-induced immunosuppression: downregulation of interleukin-2, interleukin-2 receptor alpha-chain, and its Jak/Stat signaling pathway. Am J Reprod Immunol. 1999. 41:61–69.
11. Markert UR, Kilic M, Schleussner E, Vogelsang H. Choriocarcinoma-induced suppression of lymphocyte activity. J Investig Allergol Clin Immunol. 2000. 10:323–326.
12. Rajashekhar G, Loganath A, Roy AC, Mongelli JM. Resistance to Fas-mediated cell death in BeWo and NJG choriocarcinoma cell lines: implications in immune privilege. Gynecol Oncol. 2003. 91:89–100.